MOORE CAPITAL MANAGEMENT, LP

Position in RVMD — Revolution Medicines, Inc.

CIK 1448574 NEW YORK, NY

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,407,100

+$978,560 QoQ

Shares Held

55,600

0.0% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MOORE CAPITAL MANAGEMENT, LP holds $51,235,346 across 22 Biotechnology names. RVMD ranks #3 (10.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMCR	Immunocore Holdings plc	197,308	$5,948,836
2	GMAB	Genmab A/S	211,705	$5,680,045
3	RVMD	Revolution Medicines, Inc. This page	55,600	$5,407,100
4	IRON	Disc Medicine, Inc.	57,796	$3,695,476
5	ATAI	AtaiBeckley Inc.	952,380	$3,371,425
6	RARE	Ultragenyx Pharmaceutical Inc.	157,132	$3,291,915
7	PTCT	Ptc Therapeutics, Inc.	44,694	$3,045,002
8	REPL	Replimune Group, Inc.	311,124	$2,380,098

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,407,100	55,600	0.0%	Shares	Sole	2026-05-15
2025-12-31	$4,428,540	55,600	0.0%	Shares	Sole	2026-02-17
2025-09-30	$2,596,520	55,600	0.0%	Shares	Sole	2025-11-14
2025-06-30	$2,045,524	55,600	0.0%	Shares	Sole	2025-08-14
2025-03-31	$1,966,016	55,600	0.0%	Shares	Sole	2025-08-12
2024-12-31	$2,431,944	55,600	0.0%	Shares	Sole	2025-02-14
2024-09-30	$2,521,460	55,600	0.0%	Shares	Sole	2024-11-14
2024-06-30	$2,157,836	55,600	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,791,988	55,600	0.0%	Shares	Sole	2024-05-15
2023-12-31	$1,594,608	55,600	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.